Naglazyme

BioMarin RareConnections Patient Guide: How to Get Naglazyme at Low or No Cost

Naglazyme (galsulfase) is an enzyme replacement therapy for patients with Mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy syndrome), a rare genetic disorder that affects the body's ability to break down certain substances, leading to buildup that can cause skeletal abnormalities, joint stiffness, heart and lung problems, and reduced endurance[1][6][7]. BioMarin RareConnections is the patient assistance program from BioMarin that helps eligible patients access Naglazyme through support with billing, insurance navigation, infusion center coordination, and financial aid like co-pay assistance[1][2][4].

About Naglazyme and MPS VI

MPS VI is a lysosomal storage disorder where the enzyme N-acetylgalactosamine 4-sulfatase is deficient, causing glycosaminoglycans (GAGs) to accumulate in tissues and organs[6][7]. This leads to symptoms like short stature, coarse facial features, hearing loss, corneal clouding, and progressive mobility issues. Naglazyme provides the missing enzyme intravenously once weekly, improving walking and stair-climbing capacity, endurance, pulmonary function, and reducing urinary GAG levels with consistent use[5][6][7].

Important Safety Note: Naglazyme carries a black box warning for hypersensitivity reactions, including anaphylaxis, which can occur during or up to 24 hours after infusion. Start treatment in a healthcare setting with monitoring and resuscitation equipment available. Common side effects include rash, pain, hives, headache, fever, and itching[3][5][7]. Always discuss risks with your doctor.

The recommended dose is 1 mg/kg body weight weekly, infused over at least 4 hours. It can be given at an infusion center, doctor's office, hospital, pharmacy, or even at home after coordination[1][3][8]. Home infusions involve receiving vials from a specialty pharmacy, storing them refrigerated, and having a nurse administer[3].

Who Qualifies for BioMarin RareConnections?

This program supports patients with a valid Naglazyme prescription facing access barriers. It offers personalized case management for coverage, financial needs, education, and infusion logistics[2][4]. Key eligibility focuses on commercially insured patients needing co-pay assistance; specific income guidelines are not publicly disclosed[program details]. It's not for government-funded insurance like Medicare or Medicaid[program details].

Income Eligibility Breakdown

Since exact Federal Poverty Level (FPL) thresholds are not disclosed, eligibility is determined case-by-case. Contact the program for personalized assessment.

Insurance Requirements

You must have commercial prescription insurance (private plans, not government programs like Medicare, Medicaid, VA, or Tricare)[program details][2][4]. The program helps with prior authorizations, appeals, and billing to streamline coverage[1][2]. Uninsured or underinsured patients may qualify for additional support—call to confirm[4].

Step-by-Step Application Process

1. Get a Prescription: Discuss Naglazyme with your doctor if you have MPS VI. They confirm diagnosis and prescribe[1][6].

2. Contact BioMarin RareConnections: Call (866) 906-6100 to start enrollment. A case manager guides you[1][3][program details].

3. Complete Forms: Sign the Patient Consent Form (PCF) online or via phone. Your doctor submits the Patient Enrollment Form (PEF)[2][4][10].

4. Submit Documents: Provide proof of income, insurance information, prescription, and doctor-completed application[program details].

5. Approval and Coordination: Case manager helps find an infusion center (or home setup), handles insurance, and ensures delivery[1][3].

6. Start Treatment: Attend first infusion in a monitored setting. Weekly infusions follow[5][8].

Applications are handled by phone; no online portal listed[program details]. Reauthorization is required periodically to continue benefits[program details][5].

Timeline and Delivery

Processing time varies; expect case manager contact soon after calling. Infusion setup depends on insurance approval—could take days to weeks[1][2]. Naglazyme arrives at your hospital, doctor's office, pharmacy, or home via specialty pharmacy[3][program details]. For home: Refrigerate vials (discard if damaged or unrefrigerated >24 hours), apply numbing cream if prescribed, stay hydrated[3]. Infusion takes ~4 hours; monitor for reactions[8].

If Denied or Alternatives

If denied, your case manager assists with appeals or alternative funding options[2][4]. No biosimilar alternatives exist for Naglazyme[program details]. Explore independent foundations, state programs, or clinical trials via your doctor. Lifelong weekly therapy is key for benefits—discuss interruptions with your physician[5].

Disclaimer

This guide is for informational purposes based on available program details as of general knowledge. Eligibility, benefits, and processes can change; always verify with BioMarin RareConnections at (866) 906-6100 or your healthcare provider. Not medical advice—consult professionals for treatment decisions. BioMarin does not guarantee coverage or assistance[1][2][program details]. (Word count: 1028)